Facet Biotech

A renewed sense that Wall Street's biggest financial companies had endured the worst of the economic downturn helped lead the stock market higher on Wednesday, The New York Times reported.

A renewed sense that Wall Street's biggest financial companies had endured the worst of the economic downturn helped lead the stock market higher on Wednesday, The New York Times reported.

Moody's Investors Service warned of a possible downgrade of Abbott Laboratories on Wednesday, citing the drug and medical products company's bid to buy Facet Biotech for $450 million.

Moody's Investors Service warned of a possible downgrade of Abbott Laboratories on Wednesday, citing the drug and medical products company's bid to buy Facet Biotech for $450 million.